Crucial laboratory parameters in COVID-19 diagnosis and prognosis: An updated meta-analysis

Gita Vita Soraya1, Zulvikar Syambani Ulhaq2

  • 1Department of Biochemistry, Faculty of Medicine, Hasanuddin University, Makassar, South Sulawesi, 90245, Indonesia.

Medicina Clinica (English Ed.)
|September 1, 2020
PubMed

Insights

Platelet count is crucial for diagnosing and predicting coronavirus disease 2019 (COVID-19) severity. Lower leukocyte and neutrophil counts suggest COVID-19 infection, while higher counts indicate disease progression.

Area of Science:

  • Medical laboratory science
  • Infectious disease diagnostics
  • Critical care medicine

Background:

  • Laboratory parameters are vital for diagnosing coronavirus disease 2019 (COVID-19).
  • Differentiating COVID-19 from non-COVID-19 pneumonia and assessing disease severity requires understanding key biomarkers.

Purpose of the Study:

  • To compare laboratory parameters between COVID-19 and non-COVID-19 pneumonia.
  • To identify laboratory differences between severe and non-severe COVID-19 cases.

Main Methods:

  • Systematic review and meta-analysis of studies published until March 2020.
  • Analysis of leukocyte, neutrophil, thrombocyte, lymphocyte counts, C-reactive protein (CRP), procalcitonin (PCT), and D-dimer levels.
  • Random-effect model applied due to heterogeneity.

Main Results:

  • COVID-19 pneumonia cases showed significantly lower leukocyte, neutrophil, and platelet counts compared to non-COVID-19 pneumonia.
  • Severe COVID-19 cases exhibited significantly lower lymphocyte and thrombocyte counts.
  • Severe COVID-19 cases also showed significantly higher leukocyte, neutrophil, D-dimer, and CRP levels.

Conclusions:

  • Thrombocyte count is a key indicator for both COVID-19 diagnosis and prognosis.
  • Low leukocyte and neutrophil counts may indicate COVID-19 infection, whereas elevated levels suggest disease progression.
  • Lymphocyte, D-dimer, and CRP levels, while not diagnostic, are indicative of COVID-19 severity.
Abstract